|
KTELC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.235800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.601800E-02 |
| Normal-vs-Stage2 |
5.000200E-01 |
| Normal-vs-Stage3 |
1.050810E-01 |
| Normal-vs-Stage4 |
2.730600E-01 |
| Stage1-vs-Stage2 |
5.360800E-01 |
| Stage1-vs-Stage3 |
9.043200E-01 |
| Stage1-vs-Stage4 |
5.729600E-01 |
| Stage2-vs-Stage3 |
5.002000E-01 |
| Stage2-vs-Stage4 |
8.371200E-01 |
| Stage3-vs-Stage4 |
5.709400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.178200E-02 |
| Normal-vs-AfricanAmerican |
5.854000E-01 |
| Normal-vs-Asian |
2.836200E-01 |
| Caucasian-vs-AfricanAmerican |
1.417790E-02 |
| Caucasian-vs-Asian |
6.621000E-01 |
| AfricanAmerican-vs-Asian |
1.047960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.232820E-01 |
| Normal-vs-Female |
7.137800E-02 |
| Male-vs-Female |
7.231400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.493200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.238400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.045400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.539200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.422600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.692600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.727400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.475800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.314100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.581400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.893770E-01 |
| Normal-vs-Grade 2 |
4.017900E-02 |
| Normal-vs-Grade 3 |
2.694800E-01 |
| Normal-vs-Grade 4 |
2.182000E-01 |
| Grade 1-vs-Grade 2 |
7.904600E-01 |
| Grade 1-vs-Grade 3 |
3.020400E-01 |
| Grade 1-vs-Grade 4 |
4.900000E-01 |
| Grade 2-vs-Grade 3 |
9.651800E-02 |
| Grade 2-vs-Grade 4 |
4.605800E-01 |
| Grade 3-vs-Grade 4 |
6.601400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.057830E-02 |
| Normal-vs-ccB subtype |
6.276100E-02 |
| ccA subtype-vs-ccB subtype |
6.092400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.791900E-02 |
| Normal-vs-N1 |
3.240600E-01 |
| N0-vs-N1 |
9.692800E-01 |
|
|
